Adaptive Biotechnologies Corp. (ADPT)
14.81
+0.38
(+2.63%)
USD |
NASDAQ |
Apr 02, 16:00
14.82
+0.01
(+0.07%)
After-Hours: 20:00
Adaptive Biotechnologies Research and Development Expense (Quarterly) : 19.89M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 3.133B |
| AptarGroup, Inc. | -- |
| AnaptysBio, Inc. | 25.43M |
| Envista Holdings Corp. | 32.10M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |